作者
Maria Pino, Amélie Pagliuzza, M Betina Pampena, Claire Deleage, Elise G Viox, Kevin Nguyen, Inbo Shim, Adam Zhang, Justin L Harper, Sadia Samer, Colin T King, Barbara Cervasi, Kiran P Gill, Stephanie Ehnert, Sherrie M Jean, Michael L Freeman, Jeffrey D Lifson, Deanna Kulpa, Michael R Betts, Nicolas Chomont, Michael M Lederman, Mirko Paiardini
发表日期
2022/8/27
期刊
Nature Communications
卷号
13
期号
1
页码范围
5055
出版商
Nature Publishing Group UK
简介
Antiretroviral therapy (ART) is not curative due to the persistence of a reservoir of HIV-infected cells, particularly in tissues such as lymph nodes, with the potential to cause viral rebound after treatment cessation. In this study, fingolimod (FTY720), a lysophospholipid sphingosine-1-phosphate receptor modulator is administered to SIV-infected rhesus macaques at initiation of ART to block the egress from lymphoid tissues of natural killer and T-cells, thereby promoting proximity between cytolytic cells and infected CD4+ T-cells. When compared with the ART-only controls, FTY720 treatment during the initial weeks of ART induces a profound lymphopenia and increases frequencies of CD8+ T-cells expressing perforin in lymph nodes, but not their killing capacity; FTY720 also increases frequencies of cytolytic NK cells in lymph nodes. This increase of cytolytic cells, however, does not limit measures of viral persistence …
引用总数
学术搜索中的文章